The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy

Cancer Gene Therapy

Volumn 7, Issue 11, 2000, Pages 1456-1468

  Grignet Debrus, Christine ^a   Cool, Vincent ^b   Baudson, Nathalie ^b   Velu, Thierry ^b   Calberg Bacq, Claire Michelle ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Bystander effect; Connexin 43; Suicide gene therapy; Viral thymidine kinases

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; CONNEXIN 43; GANCICLOVIR; PRODRUG; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SORIVUDINE; THYMIDINE KINASE; VIRUS ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER GROWTH; CARCINOGENICITY; CELL CONTACT; DRUG EFFECT; DRUG EFFICACY; FEMALE; GAP JUNCTION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GLIOBLASTOMA; GROWTH INHIBITION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUICIDE GENE; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 3; SIMPLEXVIRUS;

EID: 0033669748     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700250     Document Type: Article

References (68)

1. Tumor chemosensitivity conferred by inserted Herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
2. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
3. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats
4. Systemic gene therapy of murine melanoma using tissue-specific expression of the HSVtk gene involves an immune component
5. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
6. Adenovirus-mediated Herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: Results of a phase I clinical trial in malignant mesothelioma
7. Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: A pilot study in humans
8. Thymidine kinase-mediated killing of rat brain tumors
9. The bystander effect: Tumor regression when a fraction of the tumor mass is genetically modified
10. The bystander effect: Association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice
11. Bystander killing induces apoptosis and is inhibited by forskolin
12. Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells
13. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSVtk retroviral gene therapy
14. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro
15. Gap junctions play a role in the bystander effect of the Herpes simplex virus thymidine kinase/ganciclovir system in vitro
16. Bystander killing of cancer cells by Herpes simplex virus thymidine kinase gene is mediated by connexins
17. Mechanism of bystander effect killing in the Herpes simplex thymidine kinase gene therapy model of cancer treatment
18. The bystander effect exerted by tumor cells expressing the Herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions
19. Intercellular communication mediates the bystander effect during Herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells
20. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene
21. Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection
22. Prodrug-activated gene therapy: Involvement of an immunological component in the bystander effect
23. Immune system in suicide gene therapy
24. A distant bystander effect of suicide gene therapy: Regression of nontransduced tumors together with a distant transduced tumor
25. In vivo analysis of the bystander effect: A cytokine cascade
26. Ganciclovir chemoablation of Herpes thymidine kinase suicide gene-modified tumors produces tumor necrosis and induces systemic immune responses
27. Development of antitumor immunity following thymidine kinase-mediated killing of experimental brain tumors
28. Varicella zoster virus thymidine kinase. Characterization and substrate specificity
29. Potential of Varicella zoster virus thymidine kinase as a suicide gene in breast cancer cells
30. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-β-D-arabinofuranosyluracil (BVaraU) against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase
31. Construction and use of a safe and efficient amphotropic packaging cell line
32. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production
33. A simple, rapid, and sensitive DNA assay procedure
34. Curative potential of Herpes simplex virus thymidine kinase gene transfer in rats with 9L
35. In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: Consequences for HSVtk/GCV anticancer gene therapy
36. Construction of retroviral packaging cell lines
37. Examples of apoptosis in the immune system
38. Scrape loading and dye transfer
39. Apigenin and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cells
40. A preloading method of evaluating gap junctional communication by fluorescent dye transfer
41. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
42. Regional differences in connexin 32 and connexin 43 messenger RNAs in rat brain
43. Differential phosphorylation of the gap junction protein connexin 43 junctional communication-competent and -deficient cell lines
44. Involvement of gap junctions in tumorigenesis: Transfection of tumor cells with connexin 32 cDNA retards growth in vivo
45. Negative growth control of HeLa cells by connexin genes: Connexin species specificity
46. Gap junctions promote the bystander effect of Herpes simplex virus thymidine kinase in vivo
47. Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid
48. Gene therapy of hepatoma: Bystander effects and nonapoptotic cell death induced by thymidine kinase and ganciclovir
49. Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes
50. Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing Herpes simplex virus thymidine kinase
51. Transcriptional down-regulation of gap junctional proteins blocks junctional communication in human mammary tumor cell lines
52. Specificity of gap junction communication among human mammary cells and connexin transfectants in culture
53. Gap junction distribution and connexin expression in human breast
54. Gap junction genes, Cx26 and Cx43, individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential
55. Properties and regulation of gap junctional hemichannels in the plasma membranes of cultured cells
56. Retinoids augment the bystander effect in vitro and in vivo in Herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy
57. Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy
58. Enhancement of the Herpes simplex virus thymidine kinase/ganciclovir by-stander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions
59. A tumor-suppressor gene, Cx26, also mediates the bystander effect in HeLa cells
60. Bystander effect of purine nucleoside analogues in HSV-1tk suicide gene therapy is superior to that of pyrimidine analogues
61. Selectivity of connexin-specific gap junctions does not correlate with channel conductance
62. Isoform composition of connexin channels determines selectivity among second messengers and uncharged molecules
63. Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocultured with Herpes simplex virus type 1 thymidine kinase-expressing human glioblastoma cells
64. Actions of HSVtk and connexin 43 gene delivery on gap junctional communication and drug sensitization in hepatocellular carcinoma
65. Tentative novel mechanism of the bystander effect in glioma gene therapy with HSV-TK/GCV system
66. A cell type- specific and gap junction-independent mechanism for the Herpes simplex virus- 1 thymidine kinase gene/ganciclovir-mediated bystander effect
67. Enzyme/prodrug gene therapy: Comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line
68. Induction of potent antitumor natural killer cell activity by Herpes simplex virus thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer